Wayne P. Rothbaum - 15 Sep 2023 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Wayne P. Rothbaum
Issuer symbol
IOVA
Transactions as of
15 Sep 2023
Transactions value $
$26,500,000
Form type
4
Filing time
15 Sep 2023, 19:12:55 UTC
Previous filing
02 Dec 2022
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Purchase $26,500,000 +5,000,000 +27.67% $5.3 23,067,333 15 Sep 2023 By Quogue Capital LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer.
F2 The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC.